March 14th, 2011
AHA Offers Qualified Endorsement of Weight-Loss Surgery
Larry Husten, PHD
For the first time, the AHA has offered a qualified endorsement of bariatric surgery. The scientific statement, published in Circulation, states that bariatric surgery is a relatively safe procedure that can lead to long-term weight loss and significantly improve health in appropriately selected obese patients who have been unable to lose weight nonsurgically.
But, said Paul Poirier, the lead author of the statement, in an AHA press release, “it is not an across-the-board endorsement of bariatric surgery for the severely obese. It is a consensus document that provides expert perspective based on the results of recent scientific studies.”
The statement notes that surgical weight loss can “completely reverse established diabetes mellitus in a large percentage of subjects” and results in improvements in lipids, inflammation, nonalcoholic fatty liver disease, hypertension, sleep apnea, and cardiac function. The report states that “there is increasing, although not definitive, evidence that bariatric surgery provides a significant survival benefit.”
Categories: General, Prevention
Tags: bariatric surgery, obesity, weight loss
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
One Response to “AHA Offers Qualified Endorsement of Weight-Loss Surgery”
Search the Archive
Archives by Date
NEJM — Recent Cardiology Articles- Thromboprophylaxis for Atrial Fibrillation in Patients with Drug-Eluting Stents February 12, 2026Stroke prevention is one of the pillars of treatment for patients with atrial fibrillation, and oral anticoagulation with a direct oral anticoagulant (DOAC) is now the preferred option for thromboprophylaxis.1 Nevertheless, patients with atrial fibrillation commonly have coexistent vascular disease, so they may present with an acute...
- Adenoviral Inciting Antigen and Somatic Hypermutation in VITT February 12, 2026VITT is caused by a somatic hypermutation of an anti–adenovirus pVII antibody that generates more avid binding of platelet factor 4 than of adenovirus pVII, its original target, which results in platelet activation.
- Case 5-2026: An 18-Year-Old Woman with Headache and Hypertension February 12, 2026An 18-year-old woman with chronic headaches was admitted to the pediatric intensive care unit for a hypertensive emergency. The potassium level was 2.0 mmol per liter. A diagnosis was made.
- Therapy for Atrial Fibrillation in Patients with Drug-Eluting Stents February 12, 2026In patients with atrial fibrillation and a drug-eluting stent placed at least 1 year earlier, monotherapy with a non–vitamin K antagonist oral anticoagulant was noninferior to combination therapy with clopidogrel for net adverse clinical events.
- LVAD February 5, 2026When a man ends up in the ED after having severed the driveline of his left ventricular assist device, the medical student on his team learns that sometimes a life saved is not the life the patient wants to live.
- Thromboprophylaxis for Atrial Fibrillation in Patients with Drug-Eluting Stents February 12, 2026
-
Tag Cloud
- ACS AF AHA anticoagulation aortic valve replacement apixaban aspirin atrial fibrillation CABG cardiovascular risk cholesterol clopidogrel dabigatran diabetes diet drug-eluting stents epidemiology ESC exercise FDA FDA approvals Fellowship training guidelines HDL heart failure hypertension ICDs MI myocardial infarction obesity PCI Primary PCI risk factors rivaroxaban statins STEMI stents stroke stroke prevention TAVI TAVR type 2 diabetes venous thromboembolism warfarin women

There is no doubt that bariatric surgery is useful in morbidly obese, but the judicious selection of patients ,taking into account their personality profile is of the utmost importance.The so called “complete reversal of diabetes” is yet to be observed on a long term basis.
Competing interests pertaining specifically to this post, comment, or both:
none